2019-09-20T09:01:00
(BPT) – Ataxia, a rare and progressive neurological disease, affects nearly 150,000 people in the U.S. A new clinical study will measure if troriluzole, an investigational drug, will improve ataxia symptoms in people with spinocerebellar ataxia (SCA). Learn more at www.scatrial.org.
